Target intelligence / Profile preview

Leishmania species parasite membranes and cellular structures

Molecular classification
Cellular structure, Lipid bilayer, Organelle
01

Overview

Leishmania spp. parasite membranes and cellular structures represent the fundamental physical and functional boundaries of the protozoan parasites responsible for leishmaniasis. These structures include the plasma membrane, which is characterized by a high concentration of ergosterol and specialized surface glycoconjugates like lipophosphoglycan (LPG) and GP63 protease, essential for survival within the host macrophage (Source: PMID: 12624100). Internal cellular structures, such as the kinetoplast (a specialized mitochondrial DNA network) and glycosomes, are vital for energy metabolism and parasite replication (Source: PMID: 25634461). The integrity of these membranes is crucial for maintaining osmotic balance and protecting the parasite from the acidic environment of the host's phagolysosome. Many frontline anti-leishmanial therapies exert their effects by compromising the integrity or function of these membranes. For example, Amphotericin B selectively binds to leishmanial ergosterol, forming lethal pores that cause ion leakage and cell lysis (Source: NIH/PubChem). Miltefosine, an oral agent, targets phospholipid metabolism and disrupts membrane-mediated signaling, leading to apoptosis-like death in the parasite (Source: PMID: 22944344).

Other names
Leishmania cell membraneLeishmanial plasma membraneLeishmania cellular organellesLeishmania surface glycoconjugates
02

Mechanism of action

Disruption of membrane integrity via ergosterol binding, inhibition of phospholipid metabolism, and interference with mitochondrial membrane potential (Source: PMID: 22944344, NIH/PubChem).

03

Biological functions

Structural integrityNutrient transportOsmotic regulationHost-pathogen interactionMetabolic compartmentalization
04

Disease associations

Infection
05

Safety considerations

NephrotoxicityTeratogenicityCardiotoxicityDevelopment of drug resistance
06

Interacting drugs

Amphotericin B

4 more in the full profile.

07

Biomarkers

Parasite DNA (qPCR)rK39 antigenK39 antibody titer

Beyond the preview

Go deeper on Leishmania species parasite membranes and cellular structures.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Leishmania species parasite membranes and cellular structures.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call